Ola Landgren Selected Research

carfilzomib

10/2022	Efficacy and safety of carfilzomib-lenalidomide-dexamethasone in newly diagnosed multiple myeloma: pooled analysis of four single-arm studies.
1/2022	Subgroup analysis based on cytogenetic risk in patients with relapsed or refractory multiple myeloma in the CANDOR study.
1/2022	Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): updated outcomes from a randomised, multicentre, open-label, phase 3 study.
11/2021	Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma: A Phase 2 Nonrandomized Controlled Trial.
6/2021	Safety and Effectiveness of Weekly Carfilzomib, Lenalidomide, Dexamethasone, and Daratumumab Combination Therapy for Patients With Newly Diagnosed Multiple Myeloma: The MANHATTAN Nonrandomized Clinical Trial.
1/2021	Tailored treatment to MRD response: A phase I/II study for newly diagnosed multiple myeloma patients using high dose twice-weekly carfilzomib (45 and 56 mg/m2 ) in combination with lenalidomide and dexamethasone.
1/2021	A phase 1b study of once-weekly carfilzomib combined with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma.
1/2020	Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): results from a randomised, multicentre, open-label, phase 3 study.
10/2019	Cereblon gene variants and clinical outcome in multiple myeloma patients treated with lenalidomide.
1/2019	Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ola Landgren Research Topics

Disease

103	Multiple Myeloma 10/2022 - 12/2006
35	Neoplasms (Cancer) 01/2022 - 05/2003
23	Monoclonal Gammopathy of Undetermined Significance 12/2021 - 12/2006
22	Residual Neoplasm 01/2022 - 07/2013
16	Smoldering Multiple Myeloma 11/2022 - 05/2011
8	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2022 - 09/2009
7	Infections 06/2021 - 12/2007
7	Disease Progression 01/2019 - 02/2010
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2020 - 04/2009
6	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2016 - 03/2009
5	Lymphoma (Lymphomas) 06/2014 - 03/2007
4	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 01/2006
4	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 06/2018 - 12/2007
4	Paraproteinemias (Monoclonal Gammopathy) 01/2016 - 10/2011
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2021 - 08/2013
3	Hodgkin Disease (Hodgkin's Disease) 01/2020 - 04/2003
3	Cardiotoxicity 11/2018 - 03/2015
3	Obesity 01/2017 - 11/2012
3	Second Primary Neoplasms (Neoplasms, Second) 10/2015 - 03/2007
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2015 - 01/2007
3	Acquired Immunodeficiency Syndrome (AIDS) 11/2012 - 05/2010
3	Autoimmune Diseases (Autoimmune Disease) 07/2011 - 09/2008
3	Lymphocytosis 01/2010 - 12/2007
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 08/2021 - 11/2010
2	Renal Insufficiency (Renal Failure) 08/2021 - 11/2014
2	Sepsis (Septicemia) 06/2021 - 03/2016
2	COVID-19 11/2020 - 06/2020
2	Hypertension (High Blood Pressure) 11/2020 - 06/2020
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2020 - 11/2008
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020 - 02/2016
2	Plasma Cell Neoplasms 01/2019 - 05/2010
2	Epstein-Barr Virus Infections 06/2018 - 06/2013
2	Overweight 01/2017 - 01/2016
2	Celiac Disease (Celiac Sprue) 11/2016 - 03/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 11/2016 - 03/2015
2	Leukemia 11/2016 - 04/2009
2	Cytopenia 08/2014 - 02/2009
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 03/2014 - 03/2005

Drug/Important Bio-Agent (IBA)

22	Biomarkers (Surrogate Marker)IBA 12/2021 - 12/2010
21	Dexamethasone (Maxidex)FDA LinkGeneric 11/2022 - 01/2011
21	Lenalidomide (CC 5013)FDA Link 10/2022 - 11/2009
20	carfilzomibIBA 10/2022 - 09/2015
18	Proteins (Proteins, Gene)FDA Link 12/2021 - 06/2010
14	Biological ProductsIBA 12/2021 - 12/2007
12	Melphalan (Alkeran)FDA LinkGeneric 08/2021 - 11/2009
10	Immunoglobulin M (IgM)IBA 01/2016 - 03/2009
9	Pharmaceutical PreparationsIBA 12/2021 - 12/2015
7	Immunoglobulin G (IgG)IBA 11/2020 - 06/2010
6	Bortezomib (Velcade)FDA Link 06/2021 - 11/2009
6	Proteasome InhibitorsIBA 06/2021 - 08/2014
6	Immunomodulating AgentsIBA 01/2020 - 11/2008
6	Immunoglobulins (Immunoglobulin)IBA 12/2019 - 03/2005
5	daratumumabIBA 01/2022 - 01/2020
5	ORALIT (ORS)IBA 04/2014 - 07/2009
5	AntigensIBA 04/2014 - 05/2003
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2016
4	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2020 - 08/2014
4	CytokinesIBA 04/2020 - 10/2011
4	Immunoglobulin A (IgA)IBA 11/2016 - 06/2010
3	Monoclonal AntibodiesIBA 05/2021 - 01/2013
3	PesticidesIBA 01/2021 - 04/2009
3	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2021 - 01/2019
3	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2011
3	Immunoglobulin Variable RegionIBA 01/2020 - 03/2005
3	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2018 - 04/2005
3	AdiponectinIBA 01/2017 - 11/2012
3	Rituximab (Mabthera)FDA Link 03/2015 - 01/2007
3	Thalidomide (Thalomid)FDA Link 01/2013 - 11/2009
3	Prednisone (Sone)FDA LinkGeneric 11/2009 - 04/2005
2	ixazomibIBA 11/2022 - 01/2020
2	ibrutinibIBA 02/2022 - 03/2021
2	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2019
2	HerbicidesIBA 01/2021 - 11/2015
2	InsecticidesIBA 01/2021 - 11/2015
2	Permethrin (Ambush)FDA LinkGeneric 01/2021 - 04/2009
2	UbiquitinIBA 10/2020 - 08/2014
2	ChemokinesIBA 04/2020 - 10/2014
2	Agent OrangeIBA 01/2020 - 11/2015
2	B-Cell Maturation AntigenIBA 01/2020 - 01/2019
2	AntibodiesIBA 10/2019 - 11/2016
2	LigandsIBA 10/2019 - 11/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 12/2012
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2019 - 08/2016
2	Cyclin DIBA 04/2017 - 03/2014
2	Hormones (Hormone)IBA 01/2017 - 04/2008
2	IPH-2101IBA 11/2016 - 06/2014
2	Histone Deacetylase InhibitorsIBA 12/2015 - 03/2014
2	Glutens (Glutelin)IBA 03/2015 - 01/2009

Therapy/Procedure

48	Therapeutics 01/2022 - 12/2006
8	Stem Cell Transplantation 01/2022 - 11/2009
8	Drug Therapy (Chemotherapy) 08/2021 - 04/2003
7	Transplantation 01/2020 - 12/2007
4	Immunotherapy 01/2022 - 11/2016
4	Radiotherapy 08/2021 - 01/2006
4	Cell Transplantation 11/2020 - 01/2009
3	Hematopoietic Stem Cell Transplantation 01/2020 - 02/2016
3	Splenectomy 02/2014 - 01/2006
2	Artificial Respiration (Mechanical Ventilation) 11/2020 - 06/2020
2	Hematopoietic Stem Cell Mobilization 01/2020 - 01/2017
2	Autologous Transplantation 01/2017 - 08/2014